Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Genome-wide screening identifies shared and specific host factors of SARS-CoV-2 and other CoVs

June 7, 2021

First subjects dosed in phase II study of ADV-110 in Australia

June 7, 2021

INO-4700 MERS-CoV vaccine candidate enters phase II studies

June 4, 2021

Novartis initiates recruitment in phase I study of INE-963

June 4, 2021

Evaxion reports preclinical proof-of-concept data for its AI-powered RAVEN vaccine platform

June 4, 2021

First patient dosed in phase I/II study of PhageBank in urinary tract infections

June 4, 2021

U.K. study identifies another danger of COVID-19: increased antibiotic resistance

June 3, 2021

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

June 3, 2021

NIH announces first-in-human study of FluMos-v1 universal influenza vaccine

June 2, 2021

Novel inhalable liposome formulations of antiviral drugs against COVID-19

June 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...